After reading for a PhD from the University of Edinburgh Dr Saliba worked as a postdoctoral fellow in the field of Inflammation and Immunity at Imperial College London (5 years) and University of Oxford (4 years). Dr. David Saliba also holds an honorary position as Research Fellow at the Kennedy Institute of Rheumatology, University of Oxford. As a postdoctoral researcher Dr. Saliba published several high impact, peer reviewed papers in journals including Nature, Cell Reports, Blood, PNAS and eLife, receiving over 700 citations in the field of immunology. He participated in EU-funded projects through European Research Council Advanced Grant (ERC-AdG), Seventh Framework Program (FP7), Human Frontier Science Project (HFSP) and Medical Research Council (MRC) grants. In the field of virology related research, Dr Saliba has also collaborated with the Center for HIV/AIDS Vaccine Immunology & Immunogen Discovery consortium. He has been recently awarded an Emanuele Cancer Research Fund to investigate the role of immune cells in Pituitary Neuroendocrine tumours. Dr Saliba, together with his collaborators at Imperial College, has also successfully applied and published a US patent application [13/978,504] on inhibitors that modulate key regulators of the immune system.
